Current trends in initial management of laryngeal cancer: the declining use of open surgery
CE Silver, JJ Beitler, AR Shaha, A Rinaldo… - European Archives of Oto …, 2009 - Springer
The role of open surgery for management of laryngeal cancer has been greatly diminished
during the past decade. The development of transoral endoscopic laser microsurgery (TLS) …
during the past decade. The development of transoral endoscopic laser microsurgery (TLS) …
Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: a systematic review and meta-analysis of …
F Petrelli, A Coinu, V Riboldi, K Borgonovo, M Ghilardi… - Oral oncology, 2014 - Elsevier
The combinations of radiotherapy (RT) plus chemotherapy (CTRT) with cisplatin or,
alternatively, RT plus cetuximab (RT+ CET), are the treatments of choice for locally …
alternatively, RT plus cetuximab (RT+ CET), are the treatments of choice for locally …
ARTSCAN III: a randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck …
M Gebre-Medhin, E Brun, P Engström… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE We performed an open-label randomized controlled phase III study comparing
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between …
JA Bonner, PM Harari, J Giralt, RB Cohen… - The lancet …, 2010 - thelancet.com
Background Previous results from our phase 3 randomised trial showed that adding
cetuximab to primary radiotherapy increased overall survival in patients with locoregionally …
cetuximab to primary radiotherapy increased overall survival in patients with locoregionally …
Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer
JJ Caudell, PE Schaner, RF Meredith, JL Locher… - International Journal of …, 2009 - Elsevier
PURPOSE: The use of altered fractionation radiotherapy (RT) regimens, as well as
concomitant chemotherapy and RT, to intensify therapy for locally advanced head-and-neck …
concomitant chemotherapy and RT, to intensify therapy for locally advanced head-and-neck …
Promising systemic immunotherapies in head and neck squamous cell carcinoma
Patients with head and neck squamous cell carcinoma (HNSCC) demonstrate poor survival
and significant treatment morbidity with standard therapy. The immune profile in HNSCC …
and significant treatment morbidity with standard therapy. The immune profile in HNSCC …
[HTML][HTML] Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for …
J Heukelom, O Hamming, H Bartelink, F Hoebers… - BMC cancer, 2013 - Springer
Background Failure of locoregional control is the main cause of recurrence in advanced
head and neck cancer. This multi-center trial aims to improve outcome in two ways. Firstly …
head and neck cancer. This multi-center trial aims to improve outcome in two ways. Firstly …
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer
L Koutcher, E Sherman, M Fury, S Wolden… - International Journal of …, 2011 - Elsevier
PURPOSE: To compare concurrent cisplatin (CDDP) and radiation (RT) with cetuximab
(C225) and RT for locally advanced head-and-neck cancer (LAHNC). METHODS AND …
(C225) and RT for locally advanced head-and-neck cancer (LAHNC). METHODS AND …
Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study
DE Heron, JCM Rwigema, MK Gibson… - American journal of …, 2011 - journals.lww.com
Purpose: Locally recurrent head and neck squamous cell carcinoma can be treated with
curative intent by surgical salvage or reirradiation with or without chemotherapy. We have …
curative intent by surgical salvage or reirradiation with or without chemotherapy. We have …
[HTML][HTML] Individualization of cancer treatment from radiotherapy perspective
A Yaromina, M Krause, M Baumann - Molecular oncology, 2012 - Elsevier
Radiotherapy is today used in about 50% of all cancer patients, often in multidisciplinary
approaches. With major advance in radiotherapy techniques, increasing knowledge on …
approaches. With major advance in radiotherapy techniques, increasing knowledge on …